2009•Journal of Pathogen BiologyRequires access

Advances in the study of the drug resistance of Candida albicans.

Wang Xiaoli, Bai Li

Open publisher page 0 citations

Abstract

This paper reviews advances in the study of the clinical drug resistance and resistance mechanisms of Candida albicans.Some resistance mechanisms of C.albicans are unclear,and new drug-resistant strains are emerging.C.albicans drug resistance must be studied further.

About this research paper

What this paper is about

This paper reviews advances in the study of the clinical drug resistance and resistance mechanisms of Candida albicans.Some resistance mechanisms of C.albicans are unclear,and new drug-resistant strains are emerging.C.albicans drug resistance must be studied further.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This paper reviews advances in the study of the clinical drug resistance and resistance mechanisms of Candida albicans.Some resistance mechanisms of C.albicans are unclear,and new drug-resistant strains are emerging.C.albicans drug resistance must be studied further.

Key concepts: Candida albicans, Drug resistance, Corpus albicans, Drug, Biology, Microbiology, Resistance (ecology), Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Advances in the study of the drug resistance of Candida albicans. — Research Paper | ScholarLens